The world of Drug Safety and Pharmacovigilance is undergoing dramatic change from simple adverse event reporting to comprehensive signal and benefit-risk management processes. In this course, attendees will be introduced to the core aspects of best practices by industry experts.
The short course will mix its lectures with practical demonstrations and roundtable discussions. It will address and advise on the interactions between different processes and groups that must be managed by a modern Drug Safety Department.
To register and see the agenda, go to THIS PAGE.